{"id":"NCT02060058","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","briefTitle":"Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy","officialTitle":"Boceprevir-based Triple Therapy to Rescue HCV Genotype 1/HBV Dually Infected Patients Refractory to Peginterferon Plus Ribavirin Combination Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2016-09","completion":"2016-09","firstPosted":"2014-02-11","resultsPosted":"2018-03-13","lastUpdate":"2018-03-13"},"enrollment":12,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C, Chronic"],"interventions":[{"type":"DRUG","name":"Stop trial intervention for boceprevir, PEG-IFN and RBV","otherNames":["Stop trial intervention for arm A","Stop trial intervention for arm B","Stop trial intervention for arm C"]}],"arms":[{"label":"Patients with 32 week therapy","type":"EXPERIMENTAL"},{"label":"Patients with 48 weeks therapy","type":"EXPERIMENTAL"},{"label":"Null responder or cirrhotic patients","type":"EXPERIMENTAL"}],"summary":"The aim of this study is to explore the efficacy and safety of boceprevir -based triple therapy to rescue HCV genotype 1 (HCV GT1)/HBV dually infected patients refractory to previous peginterferon (PEG-IFN) plus ribavirin (RBV) combination therapy.","primaryOutcome":{"measure":"Number of Full Analysis Set Participants Who Received HCV Anti-viral Therapy With Sustained Virological Response (SVR)","timeFrame":"week 24","effectByArm":[{"arm":"Patients With 32 Week Therapy","deltaMin":4,"sd":null},{"arm":"Null Responder or Cirrhotic Patients","deltaMin":4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.01"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":1,"countries":["Taiwan"]},"refs":{"pmids":["7689504","1909259","21371579","22450396","275454","1113797","8383160","20837342","19669238","21859997","19084016","18490077","19602134","21449784","21696308","23322699"],"seeAlso":["https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202258orig1s000toc.cfm"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":4},"commonTop":["Gastroenterology","Dermatology"]}}